TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
TwoStep Therapeutics has raised $21.1M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
TwoStep Therapeutics's investors include NFX, Alexandria Venture Investments, 2048 Ventures, GC&H Investments.
TwoStep Therapeutics is headquartered in Palo Alto, United States.
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
TwoStep Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TwoStep Therapeutics — Funding & Investors." VCBacked, January 20, 2026, https://www.vcbacked.co/company/twostep-therapeutics. Accessed July 29, 2026.
VCBacked. (2026). TwoStep Therapeutics — Funding & Investors. Retrieved July 29, 2026, from https://www.vcbacked.co/company/twostep-therapeutics
{{cite web |title=TwoStep Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/twostep-therapeutics |website=VCBacked |access-date=July 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated